ArticleOncotarget2014

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.

Michaela Aichler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.